Aortic Single-Cell Transcriptome Analysis Reveals ApoE-Isoform-Specific Influences on Vascular Disease
Abstract
1. Introduction
2. Results
2.1. Human apoE Polymorphism Differentially Impacts Western Diet-Induced Atherosclerosis in Mice
2.2. ApoE Isoform-Specific Differences in Vascular Gene Expression in Response to Western Diet Feeding
2.3. ApoE Isoform-Dependent Differences in Cell Composition in the Aorta of Western Diet-Fed Mice
2.4. Macrophage Repertoire Differences in the Aortas of Western Diet-Fed APOE Gene Replacement Mice
2.5. Lymphocyte Subset Differences in Aortas of Western Diet-Fed APOE Gene Replacement Mice
2.6. Endothelial Cell Differences in the Aortas of APOE2, APOE3, and APOE4 Mice
2.7. APOE Genotype Differentially Affects Fibroblast and Fibroblast-like Cell Composition in Mouse Aorta
2.8. APOE Genotype Influence on Aortic Smooth Muscle Cell Phenotype Composition
3. Discussion
4. Materials and Methods
4.1. Animals and Diets
4.2. Plasma Lipid Measurement
4.3. Atherosclerotic Lesion Analysis
4.4. Aortic mRNA Expression Analysis
4.5. Single-Cell RNA Sequencing
4.6. Single-Cell RNA Sequencing Data Analysis
4.7. Statistics
5. Conclusions
Limitations of the Study
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| Apo | Apolipoprotein |
| ACTA2 | Smooth muscle α-actin |
| BAFFR | B cell-activating factor receptor |
| CD36 | Cluster of differentiation 36 |
| CD45 | Cluster of differenetiation 45 |
| ESAM | Endothelial cell-selective adhesion molecule |
| FABP4 | Fatty acid binding protein 4 |
| GPIHBP1 | Glycosylphosphatidylinositol anchored HDL binding protein 1 |
| ICAM1/2 | Intercellular adhesion molecule ½ |
| LDL | Low density lipoprotein |
| LPL | Lipoprotein lipase |
| MAP | Mitogen-activated protein |
| MYH11 | Myosin heavy chain 11 |
| PECAM1 | Platelet endothelial cell adhesion molecule 1 |
| scRNA-seq | Single cell RNA-sequencing |
| SOX17 | SRY-box transcription factor |
| TAGLN | Transgelin/SM22a |
| UMAP | Uniform manifold approximation and projection |
| VCAM1 | Vascular cell adhesion protein 1 |
References
- Mahley, R.W.; Weisgraber, K.H.; Huang, Y. Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS. J. Lipid Res. 2009, 50, S183–S188. [Google Scholar] [CrossRef] [PubMed]
- Blazejewska-Hyzorek, B.; Gromadzka, G.; Skowronska, M.; Czlonkowska, A. APOE ε2 allele is an independent risk factor for vulnerable carotid plaque in ischemic stroke patients. Neurol. Res. 2014, 36, 950–954. [Google Scholar] [CrossRef] [PubMed]
- Couderc, R.; Mahieux, F.; Bailleul, S.; Fenelon, G.; Mary, R.; Fermanian, J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993, 24, 661–664. [Google Scholar] [CrossRef] [PubMed]
- de Andrade, M.; Thandi, I.; Brown, S.; Gotto, A., Jr.; Patsch, W.; Boerwinkle, E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am. J. Hum. Genet. 1995, 56, 1379–1390. [Google Scholar] [PubMed]
- Kalix, B.; Meynet, M.C.; Garin, M.C.; James, R.W. The apolipoprotein epsilon2 allele and the severity of coronary artery disease in Type 2 diabetic patients. Diabet. Med. 2001, 18, 445–450. [Google Scholar] [CrossRef] [PubMed]
- Vaisi-Raygani, A.; Rahimi, Z.; Nomani, H.; Tavilani, H.; Pourmotabbed, T. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients. Clin. Biochem. 2007, 40, 1150–1156. [Google Scholar] [CrossRef] [PubMed]
- Song, Y.; Stampfer, M.J.; Liu, S. Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 2004, 141, 137–147. [Google Scholar] [CrossRef] [PubMed]
- Lahoz, C.; Schaefer, E.J.; Cupples, L.A.; Wilson, P.W.F.; Levy, D.; Osgood, D.; Parpos, S.; Pedro-Botet, J.; Daly, J.A.; Ordovas, J.M. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 2001, 154, 529–537. [Google Scholar] [CrossRef] [PubMed]
- Strittmatter, W.J.; Roses, A.D. Apolipoprotein E and Alzheimer’s disease. Annu. Rev. Neurosci. 1996, 19, 53–77. [Google Scholar] [CrossRef]
- Suri, S.; Heise, V.; Trachtenberg, A.J.; Mackay, C.E. The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of apoE ε2. Neurosci. Biobehav. Rev. 2013, 37, 2878–2886. [Google Scholar] [CrossRef] [PubMed]
- Genin, E.; Hannequin, D.; Wallon, D.; Sleegers, K.; Hiltunen, M.; Combarros, O.; Bullido, M.J.; Engelborghs, S.; De Deyn, P.; Berr, C.; et al. APOE and Alzheimer disease: A major gene with semi-dominant inheritance. Mol. Psychiatry 2011, 16, 903–907. [Google Scholar] [CrossRef] [PubMed]
- Farrer, L.A.; Cupples, L.A.; Haines, J.L.; Hyman, B.; Kukull, W.A.; Mayeux, R.; Myers, R.H.; Pericak-Vance, M.A.; Risch, N.; van Duijn, C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease. Meta Analysis. Consortium. JAMA 1997, 278, 1349–1356. [Google Scholar] [CrossRef]
- Rebeck, G.W.; Kindy, M.; LaDu, M.J. Apolipoprotein E and Alzheimer’s disease: The protective effects of apoE2 and E3. J. Alzheimers Dis. 2002, 4, 145–154. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.; Zhou, B.; Wernig, M.; Sudhof, T.C. ApoE2, apoE3, and apoE4 differentially stimulae APP transcription and Abeta secretion. Cell 2017, 168, 427–441.e21. [Google Scholar] [CrossRef] [PubMed]
- Huang, Y.-W.A.; Zhou, B.; Nabet, A.M.; Wernig, M.; Sudhof, T.C. Differential signaling mediated by apoE2, apoE3, and apoE4 in human neurons parallels Alzheimer’s disease risk. J. Neurosci. 2019, 39, 7408–7427. [Google Scholar] [CrossRef] [PubMed]
- Liu, C.-C.; Wang, N.; Chen, Y.; Inoue, Y.; Shue, F.; Ren, Y.; Wang, M.; Qiao, W.; Ikezu, T.C.; Li, Z.; et al. Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer’s disease. Nat. Immunol. 2023, 24, 1854–1866. [Google Scholar] [CrossRef] [PubMed]
- Alagarsamy, J.; Jaeschke, A.; Hui, D.Y. Apolipoprotein E in cardiometabolic and neurological health and diseases. Int. J. Mol. Sci. 2022, 23, 9892. [Google Scholar] [CrossRef] [PubMed]
- Pendse, A.A.; Arbones-Mainar, J.M.; Johnson, L.A.; Altenburg, M.K.; Maeda, N. Apolipoprotein E knock-out and knock-in mice: Atherosclerosis, metabolic syndrome, and beyond. J. Lipid Res. 2009, 50, S178–S182. [Google Scholar] [CrossRef] [PubMed]
- Mahley, R.W.; Huang, Y.; Rall, S.C. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): Questions, quandaries, and paradoxes. J. Lipid Res. 1999, 40, 1933–1949. [Google Scholar] [CrossRef]
- Ulrich, V.; Konaniah, E.S.; Herz, J.; Gerard, R.D.; Jung, E.; Yuhanna, I.S.; Ahmed, M.; Hui, D.Y.; Mineo, C.; Shaul, P.W. Genetic variants of apoE and apoER2 differentially modulate endothelial function. Proc. Natl. Acad. Sci. USA 2014, 111, 13493–13498. [Google Scholar] [CrossRef] [PubMed]
- Zanotti, I.; Pedrelli, M.; Poti, F.; Stomeo, G.; Gomaraschi, M.; Calabresi, L.; Bernini, F. Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 74–80. [Google Scholar] [CrossRef] [PubMed]
- Murphy, A.J.; Akhtari, M.; Tolani, S.; Pagler, T.A.; Bijl, N.; Kuo, C.-L.; Wang, M.; Sanson, M.; Abramowicz, S.; Welch, C.; et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Investig. 2011, 121, 4138–4149. [Google Scholar] [CrossRef] [PubMed]
- Linton, M.F.; Atkinson, J.B.; Fazio, S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science 1995, 267, 1034–1037. [Google Scholar] [CrossRef] [PubMed]
- van Eck, M.; Herijgers, N.; Vidgeon-Hart, M.; Pearce, N.J.; Hoogerbrugge, P.M.; Groot, P.H.E.; Van Berkel, T.J.C. Accelerated atherosclerosis in C57BL/6 mice transplanted with apoE-deficient bone marrow. Atherosclerosis 2000, 150, 71–80. [Google Scholar] [CrossRef] [PubMed]
- Igel, E.; Haller, A.; Wolfkiel, P.R.; Orr-Asman, M.; Jaeschke, A.; Hui, D.Y. Distinct pro-inflammatory properties of myeloid cell-derived apolipoprotein E2 and E4 in atherosclerosis promotion. J. Biol. Chem. 2021, 297, 101106. [Google Scholar] [CrossRef] [PubMed]
- Cash, J.G.; Kuhel, D.G.; Basford, J.E.; Jaeschke, A.; Chatterjee, T.K.; Weintraub, N.L.; Hui, D.Y. Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress. J. Biol. Chem. 2012, 287, 27876–27884. [Google Scholar] [CrossRef] [PubMed]
- Majack, R.A.; Castle, C.K.; Goodman, L.V.; Weisgraber, K.H.; Mahley, R.W.; Shooter, E.M.; Gebicke-Haerter, P.J. Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J. Cell Biol. 1988, 107, 1207–1213. [Google Scholar] [CrossRef] [PubMed]
- Ishigami, M.; Swertfeger, D.K.; Granholm, N.A.; Hui, D.Y. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase. J. Biol. Chem. 1998, 273, 20156–20161. [Google Scholar] [CrossRef] [PubMed]
- Ishigami, M.; Swertfeger, D.K.; Hui, M.S.; Granholm, N.A.; Hui, D.Y. Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1020–1026. [Google Scholar] [CrossRef] [PubMed]
- Sullivan, P.M.; Mezdour, H.; Quarfordt, S.H.; Maeda, N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse apoE with human apoE*2. J. Clin. Investig. 1998, 102, 130–135. [Google Scholar] [CrossRef] [PubMed]
- Knouff, C.; Hinsdale, M.E.; Mezdour, H.; Altenburg, M.K.; Watanabe, M.; Quarfordt, S.H.; Sullivan, P.M.; Maeda, N. ApoE structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Investig. 1999, 103, 1579–1586. [Google Scholar] [CrossRef] [PubMed]
- Galkina, E.; Ley, K. Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2292–2301. [Google Scholar] [CrossRef] [PubMed]
- Rong, J.X.; Shapiro, M.; Trogan, E.; Fisher, E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc. Natl. Acad. Sci. USA 2003, 100, 13531–13536. [Google Scholar] [CrossRef] [PubMed]
- Bashore, A.C.; Chung, A.; Ibikunle, C.; Yan, H.; Xue, C.; Li, M.; Bauer, R.C.; Reilly, M.P. Single-cell multimodal profiling of atherosclerosis identifies CD200 as a cell surface lineage marker of vascular smooth muscle cells and their derived cells. Circulation 2024, 149, 1231–1233. [Google Scholar] [CrossRef] [PubMed]
- Wculek, S.K.; Heras-Murillo, I.; Mastrangelo, A.; Mananes, D.; Galan, M.; Miguel, V.; Curtabbi, A.; Barbas, C.; Chandel, N.S.; Enriquez, J.A.; et al. Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis. Immunity 2023, 56, 516–530.e9. [Google Scholar] [CrossRef] [PubMed]
- Liu, Y.; Xu, R.; Gu, H.; Zhang, E.; Qu, J.; Cao, W.; Huang, X.; Yan, H.; He, J.; Cai, Z. Metabolic reprogramming in macrophage responses. Biomark. Res. 2021, 9, 1. [Google Scholar] [CrossRef] [PubMed]
- Guo, X.; Li, B.; Wen, C.; Zhang, F.; Xiang, X.; Nie, L.; Chen, J.; Mao, L. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis. Cell. Mol. Life Sci. 2023, 80, 137. [Google Scholar] [CrossRef] [PubMed]
- Bain, J.-H.; Yuan, C.-Z.; Gu, J.-X.; Lin, W.-F.; Xiong, J.-Q.; Tang, Z.-W.; Li, A.; Shao, Y.-F. TREM2 modulates macrophage pyroptosis and inflammatory responses to ameliorate aortic valve calcification. Int. Immunopharmacol. 2025, 149, 114161. [Google Scholar] [CrossRef] [PubMed]
- Patterson, M.T.; Firulyova, M.M.; Xu, Y.; Hillman, H.; Bishop, C.; Zhu, A.; Hickok, G.H.; Schrank, P.R.; Ronayne, C.E.; Caillot, Z.; et al. Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis. Nat. Cardiovasc. Res. 2023, 2, 1015–1031. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Jiang, M.; Bao, H.; Huang, R.; Chen, B.; Wu, C.; Wang, H.; Luo, Z.; Li, W. Exendin-4 prevents oxLDL-induced upregulation of TREM2 and attenuates foam cell formation and inflammation in macrophages. Biochem. Pharmacol. 2025, 242, 117306. [Google Scholar] [CrossRef] [PubMed]
- Perry, H.M.; Bender, T.P.; McNamara, C.A. B cell subsets in atherosclerosis. Front. Immunol. 2012, 3, 373. [Google Scholar] [CrossRef] [PubMed]
- Winkels, H.; Ehinger, E.; Vassallo, M.; Buscher, K.; Dinh, H.Q.; Kobiyama, K.; Hamers, A.A.J.; Cochain, C.; Vafadarnejad, E.; Saliba, A.-E.; et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ. Res. 2018, 122, 1675–1688. [Google Scholar] [CrossRef] [PubMed]
- Muranski, P.; Restifo, N.P. Essentials of Th17 cell commitment and plasticity. Blood 2013, 121, 2402–2414. [Google Scholar] [CrossRef] [PubMed]
- Li, K.; Ching, D.; Luk, F.S.; Raffai, R.L. Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis. Circ. Res. 2015, 117, e1–e11. [Google Scholar] [CrossRef] [PubMed]
- Bonacina, F.; Coe, D.; Wang, G.; Longhi, M.P.; Baragetti, A.; Moregola, A.; Garlaschelli, K.; Uboldi, P.; Pellegatta, F.; Grigore, L.; et al. Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation. Nat. Commun. 2018, 9, 3083. [Google Scholar] [CrossRef] [PubMed]
- Kim, D.; Grath, A.; Lu, Y.W.; Chung, K.; Winkelman, M.; Schwarz, J.J.; Dai, G. Sox17 mediates adult arterial endothelial cell adaptation to hemodynamics. Biomaterials 2023, 293, 121946. [Google Scholar] [CrossRef] [PubMed]
- Gonzalez-Hernandez, S.; Gomez, M.J.; Sanchez-Cabo, F.; Mendez-Ferrer, S.; Munoz-Canoves, P.; Isern, J. Sox17 controls emergence and remodeling of nestin-expressing coronary vessels. Circ. Res. 2020, 127, e252–e270. [Google Scholar] [CrossRef] [PubMed]
- Kitagawa, K.; Matsumoto, M.; Sasaki, T.; Hashimoto, H.; Kuwabara, K.; Ohtsuki, T.; Hori, M. Involvement of ICAM-1 in the progression of atherosclerosis in ApoE-knockout mice. Atherosclerosis 2002, 160, 305–310. [Google Scholar] [CrossRef] [PubMed]
- Schenkel, A.R.; Mamdouh, Z.; Muller, W.A. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat. Immunol. 2004, 5, 393–400. [Google Scholar] [CrossRef] [PubMed]
- Woodfin, A.; Voisin, M.-B.; Nourshargh, S. PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2514–2523. [Google Scholar] [CrossRef] [PubMed]
- Ley, K.; Huo, Y. VCAM-1 is critical in atherosclerosis. J. Clin. Investig. 2001, 107, 1209–1210. [Google Scholar] [CrossRef] [PubMed]
- Muhl, L.; Genove, G.; Leptidis, S.; Liu, J.; He, L.; Mocci, G.; Sun, Y.; Gustafsson, S.; Buyandelger, B.; Chivukula, I.V.; et al. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat. Commun. 2020, 11, 3953, Correction in Nat. Commun. 2020, 11, 4493. https://doi.org/10.1038/s41467-020-18511-8. [Google Scholar] [CrossRef] [PubMed]
- van Kuijk, K.; McCracken, I.R.; Tillie, R.J.H.A.; Asselberghs, S.E.J.; Kheder, D.A.; Muitjens, S.; Jin, H.; Taylor, R.S.; Schreur, R.W.; Kuppe, C.; et al. Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol. Cardiovasc. Res. 2023, 119, 1509–1523. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.; Wang, M.; Lu, Y.; Ji, Y.; Simal-Candara, J.; Xiao, F.; Liu, Y.; Zhang, L.; Battino, M.; Li, P.; et al. Single-cell transcriptomics reveals the difference of aortic atherosclerosis response to phytosterols and oxidation products of sterols. Mol. Nutr. Food Res. 2023, 67, 2200811. [Google Scholar] [CrossRef] [PubMed]
- Gauthier, V.; Kyriazi, M.; Nefla, M.; Pucino, V.; Raza, K.; Buckley, C.D.; Alsaleh, G. Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing. Front. Immunol. 2023, 14, 1137659. [Google Scholar] [CrossRef] [PubMed]
- Pan, H.; Reilly, M.P. A protective smooth muscle cell transition in atherosclerosis. Nat. Med. 2019, 25, 1194–1195. [Google Scholar] [CrossRef] [PubMed]
- Yap, C.; Mieremet, A.; de Vries, C.J.; Micha, D.; de Waard, V. Six shades of vascular smooth muscle cells illuminated by KLF4 (Kruppel-like factor 4). Arterioscler. Thromb. Vasc. Biol. 2021, 41, 2693–2707. [Google Scholar] [CrossRef] [PubMed]
- Shan, F.; Huang, Z.; Xiong, R.; Huang, Q.-Y.; Li, J. HIF1α induced upregulation of KLF4 promotes migration of human vascular smooth muscle cells under hypoxia. J. Cell. Physiol. 2020, 235, 141–150. [Google Scholar] [CrossRef] [PubMed]
- Neuville, P.; Geinoz, A.; Benzonana, G.; Redard, M.; Gabbiani, F.; Ropraz, P.; Gabbiani, G. Cellular retinol binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cell sin vitro and in vivo. Am. J. Pathol. 1997, 150, 509–521. [Google Scholar] [PubMed]
- Dobnikar, L.; Taylor, A.L.; Chappell, J.; Oldach, P.; Harman, J.L.; Oerton, E.; Dzierzak, E.; Bennett, M.R.; Spivakov, M.; Jorgensen, H.F. Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels. Nat. Commun. 2018, 9, 4567, Correction in Nat. Commun. 2018, 9, 5401. https://doi.org/10.1038/s41467-018-07887-3. [Google Scholar] [CrossRef] [PubMed]
- Scheede-Bergdahl, C.; Bergdahl, A. Adaptation of mitochondrial expression and ATP production in dedifferentiating vascular smooth muscle cells. Can. J. Physiol. Pharmacol. 2017, 95, 1473–1479. [Google Scholar] [CrossRef] [PubMed]
- Yin, J.; Xia, W.; Wu, M.; Zhang, Y.; Huang, S.; Zhang, A.; Jia, Z. Inhibition of mitochondrial complex I activity attenuates neointimal hyperplasia by inhibiting smooth muscle cell proliferation and migration. Chem. Biol. Interact. 2019, 304, 73–82. [Google Scholar] [CrossRef] [PubMed]
- Mahley, R.W.; Angelin, B. Type III hyperlipoproteinemia: Recent insights into the genetic defect of familial dysbetalipoproteinemia. Adv. Intern. Med. 1984, 29, 385–411. [Google Scholar] [PubMed]
- Sullivan, P.M.; Mezdour, H.; Aratani, Y.; Knouff, C.; Najib, J.; Reddick, R.L.; Quarfordt, S.H.; Maeda, N. Targeted replacement of the mouse apolipoprotein E gene with the common human apoE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 1997, 272, 17972–17980. [Google Scholar] [CrossRef] [PubMed]
- Swirski, F.K.; Libby, P.; Aikawa, E.; Alcaide, P.; Luscinskas, F.W.; Weissleder, R.; Pittet, M.J. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Investig. 2007, 117, 195–205. [Google Scholar] [CrossRef] [PubMed]
- Jaffe, I.Z.; Karumanchi, S.A. Lipid droplets in the endothelium: The missing link between metabolic syndrome and cardiovascular disease. J. Clin. Investig. 2024, 134, e176347. [Google Scholar] [CrossRef] [PubMed]
- Allan, L.L.; Hoefl, K.; Zheng, D.-J.; Chung, B.K.; Kozak, F.K.; Tan, R.; van den Elzen, P. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 2009, 114, 2411–2416. [Google Scholar] [CrossRef] [PubMed]
- Victor, M.B.; Leary, N.; Luna, X.; Meharena, H.S.; Scannail, A.N.; Bozzelli, P.L.; Samaan, G.; Murdock, M.H.; von Maydell, D.; Effenberger, A.H.; et al. Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity. Cell Stem Cell 2022, 29, 1197–1212.e8. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Zhao, S.; Zhou, Y.; Wang, L.; Chen, Q.; Zheng, K. APOE4 reprograms microglial lipid metabolism in Alzheimer’s disease: Mechanisms and therapeutic implications. Biosci. Trends 2026, 19, 641–658. [Google Scholar] [CrossRef] [PubMed]
- Altenburg, M.; Johnson, L.; Wilder, J.; Maeda, N. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner. J. Biol. Chem. 2007, 282, 7817–7824. [Google Scholar] [CrossRef] [PubMed]
- Abimannan, T.; Peroumal, D.; Parida, J.R.; Bark, P.K.; Padhan, P.; Devadas, S. Oxidative sterss modulates the cytokine response of differentiated Th17 and Th1 cells. Free Radic. Biol. Med. 2016, 99, 352–363. [Google Scholar] [CrossRef] [PubMed]
- Muldoon, M.F.; Marsland, A.; Flory, J.D.; Rabin, B.S.; Whiteside, T.L.; Manuck, S.B. Immune system differences in men with hypo- or hypercholesterolemia. Clin. Immunol. Immunopathol. 1997, 84, 145–149. [Google Scholar] [CrossRef] [PubMed]
- Tillmanns, J.; Widera, C.; Habbaba, Y.; Paolo, G.; Kempf, T.; Wollert, K.C.; Bauersachs, J. Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA. Int. J. Cardiol. 2013, 168, 3926–3931. [Google Scholar] [CrossRef] [PubMed]
- Sieweke, J.-T.; Grosse, G.M.; Weissenborn, K.; Derda, A.A.; Biber, S.; Bauersachs, J.; Bovendiek, U.; Tillmanns, J. Circulating fibroblast activation protein α is reduced in acute ischemic stroke. Front. Cardiovasc. Med. 2022, 9, 1064157. [Google Scholar] [CrossRef] [PubMed]
- Zeleny, M.; Swertfeger, D.K.; Weisgraber, K.H.; Hui, D.Y. Distinct apolipoprotein E isoform preference for inhibition of smooth muscle cell migration and proliferation. Biochemistry 2002, 41, 11820–11823. [Google Scholar] [CrossRef] [PubMed]
- Turkson, V.; Haller, A.; Jaeschke, A.; Hui, D.Y. ApoE receptor-2 R952Q variant in macrophages elevates soluble LRP1 to potentiate hyperlipidemia and accelerate atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 2025, 45, 37–48. [Google Scholar] [CrossRef] [PubMed]
- Zheng, G.X.; Terry, J.M.; Belgrader, P.; Ryvkin, P.; Bent, Z.W.; Wilson, R.; Ziraldo, S.B.; Wheeler, T.D.; McDermott, G.P.; Zhu, J.; et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 2017, 8, 14049. [Google Scholar] [CrossRef] [PubMed]
- Hao, Y.; Hao, S.; Andersen-Nissen, E.; Mauck, W.M., 3rd; Zheng, S.; Butler, A.; Lee, M.J.; Wilk, A.J.; Darby, C.; Zager, M.; et al. Integrated analysis of multimodal single-cell data. Cell 2021, 184, 3573–3587e29. [Google Scholar] [CrossRef] [PubMed]
- Choudhary, S.; Satija, R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 2022, 23, 27. [Google Scholar] [CrossRef] [PubMed]
- Stuart, T.; Butler, A.; Hoffman, P.; Hafemeister, C.; Papalexi, E.; Mauck, W.M., 3rd; Hao, Y.; Stoeckius, M.; Smibert, P.; Satija, R. Comprehensive Integration of Single-Cell Data. Cell 2019, 177, 1888–1902 e21. [Google Scholar] [CrossRef] [PubMed]
- Blondel, V.D.; Guillaume, J.-L.; Lambiotte, R.; Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. 2008, P10008. [Google Scholar] [CrossRef]
- Levine, J.H.; Simonds, E.F.; Bendall, S.C.; Davis, K.L.; Amir, E.A.D.; Tadmor, M.D.; Litvin, O.; Fienberg, H.G.; Jager, A.; Zunder, E.R.; et al. Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis. Cell 2015, 162, 184–197. [Google Scholar] [CrossRef] [PubMed]
- Becht, E.; McInnes, L.; Healy, J.; Dutertre, C.A.; Kwok, I.W.H.; Ng, L.G.; Ginhoux, F.; Newell, E.W. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 2018, 37, 38–44. [Google Scholar] [CrossRef] [PubMed]
- Law, C.W.; Chen, Y.; Shi, W.; Smyth, G.K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014, 15, R29. [Google Scholar] [CrossRef] [PubMed]
- Subramanian, A.; Tamayo, P.; Mootha, V.K.; Mukherjee, S.; Ebert, B.L.; Gillette, M.A.; Paulovich, A.; Pomeroy, S.L.; Golub, T.R.; Lander, E.S.; et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102, 15545–15550. [Google Scholar] [CrossRef] [PubMed]
- Korotkevich, G.; Sukhov, V.; Budin, N.; Shpak, B.; Artyomov, M.N.; Sergushichev, A. Fast gene set enrichment analysis. bioRxiv 2021, 060012. [Google Scholar] [CrossRef]
- Kanehisa, M.; Furumichi, M.; Tanabe, M.; Sato, Y.; Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017, 45, D353–D361. [Google Scholar] [CrossRef] [PubMed]
- Mitrea, C.; Taghavi, Z.; Bokanizad, B.; Hanoudi, S.; Tagett, R.; Donato, M.; Voichita, C.; Draghici, S. Methods and approaches in the topology-based analysis of biological pathways. Front. Physiol. 2013, 4, 278. [Google Scholar] [CrossRef] [PubMed]
- Liberzon, A.; Birger, C.; Thorvaldsdottir, H.; Ghandi, M.; Mesirov, J.P.; Tamayo, P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015, 1, 417–425. [Google Scholar] [CrossRef] [PubMed]
- Ouyang, J.F.; Kamaraj, U.S.; Cao, E.Y.; Rackham, O.J.L. ShinyCell: Simple and sharable visualization of single-cell gene expression data. Bioinformatics 2021, 37, 3374–3376. [Google Scholar] [CrossRef] [PubMed]
- Gu, W.; Ni, Z.; Tan, Y.-Q.; Deng, J.; Zhang, S.-J.; Lv, Z.-C.; Wang, X.-J.; Chen, T.; Zhang, Z.; Hu, Y.; et al. Adventitial cell atlas of wt (wild type) and apoE (apolipoprotien E)-deficient mice defined by single-cell RNA sequencing. Arterioscler. Thromb. Vasc. Biol. 2019, 39, 1055–1071. [Google Scholar] [CrossRef] [PubMed]
- Lysaker, C.R.; Johnson, C.N.; Csikos, V.; Franczak, E.; Tetlow, A.L.; Benson, M.; Thyfault, J.P.; Geiger, P.C.; Morris, J.K.; Wilkins, H.M. APOE4 drives widespread changes to the hepatic proteome and alters metabolic function. iScience 2026, 29, 115035. [Google Scholar] [CrossRef] [PubMed]








| Name | Forward Primer | Reverse Primer |
|---|---|---|
| β-actin | ACGGCCAGGTCATCACTATTG | CAAGAAGGAAGGCTGGAAAAGA |
| Cd45 | GAGCATTCCACGGGTATTCAG | ACACGGTTATAATCATAGGGAAGAATGT |
| Cd68 | TTTCTCCAGCTGTTCACCTTGA | CCCGAAGTGTCCCTTGTCA |
| Ly6c | TGCTATGGAGTGCCAATTGAGA | GAGCAATGCAGAATCCATCAGA |
| Emr1 (F4/80) | TGTCTGACAATTGGGATCTGCCCT | ATACGTTCCGAGAGTGTTGTGGCA |
| Pecam1 | TGCGGTGGTTGTCATTGG | TGTTTGGCCTTGGCTTTCC |
| Vcam1 | ATCTCCCCTGAATACAAAACGATT | GCCCGTAGTGCTGCAAGTG |
| Acta2 (SM-α-actin) | TCCCTGGAGAAGAGCTACGAACT | AAGCGTTCGTTTCCAATGGT |
| Myh11 | TTCGCCCAAGTGACTTTTTTAGT | GGGTGCAAATAAGTGTGATTGC |
| Tagln (SM22a) | CACAAACGACCAAGCCTTCTC | TCGGCTCATGCCGTAGGA |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Hui, D.Y.; Alagarsamy, J.; Haller, A.; Medvedovic, M.; Jaeschke, A. Aortic Single-Cell Transcriptome Analysis Reveals ApoE-Isoform-Specific Influences on Vascular Disease. Int. J. Mol. Sci. 2026, 27, 5619. https://doi.org/10.3390/ijms27125619
Hui DY, Alagarsamy J, Haller A, Medvedovic M, Jaeschke A. Aortic Single-Cell Transcriptome Analysis Reveals ApoE-Isoform-Specific Influences on Vascular Disease. International Journal of Molecular Sciences. 2026; 27(12):5619. https://doi.org/10.3390/ijms27125619
Chicago/Turabian StyleHui, David Y., Jeyashree Alagarsamy, April Haller, Mario Medvedovic, and Anja Jaeschke. 2026. "Aortic Single-Cell Transcriptome Analysis Reveals ApoE-Isoform-Specific Influences on Vascular Disease" International Journal of Molecular Sciences 27, no. 12: 5619. https://doi.org/10.3390/ijms27125619
APA StyleHui, D. Y., Alagarsamy, J., Haller, A., Medvedovic, M., & Jaeschke, A. (2026). Aortic Single-Cell Transcriptome Analysis Reveals ApoE-Isoform-Specific Influences on Vascular Disease. International Journal of Molecular Sciences, 27(12), 5619. https://doi.org/10.3390/ijms27125619

